牛牛AI助理已提取核心訊息
Marc Feldmann, associated with 180 Life Sciences Corp. [ATNF], was granted 135,377 shares of common stock on December 28, 2023. The transaction, which is currently in progress, was conducted at no cost to Feldmann. Following this grant, Feldmann's direct holdings in the company increased to a total of 250,874 shares of common stock. The nature of the transaction indicates a direct acquisition of shares, reflecting a potential increase in Feldmann's vested interest in the company.
Marc Feldmann, associated with 180 Life Sciences Corp. [ATNF], was granted 135,377 shares of common stock on December 28, 2023. The transaction, which is currently in progress, was conducted at no cost to Feldmann. Following this grant, Feldmann's direct holdings in the company increased to a total of 250,874 shares of common stock. The nature of the transaction indicates a direct acquisition of shares, reflecting a potential increase in Feldmann's vested interest in the company.
與180生命科學公司 [ATNF] 相關的馬克·費爾德曼於2023年12月28日獲得135,377股普通股。該交易目前正在進行中，是費爾德曼免費進行的。在這筆贈款之後，費爾德曼在該公司的直接持股量增加到總共250,874股普通股。該交易的性質表明直接收購了股份，這反映了費爾德曼在公司的既得權益的潛在增加。
與180生命科學公司 [ATNF] 相關的馬克·費爾德曼於2023年12月28日獲得135,377股普通股。該交易目前正在進行中，是費爾德曼免費進行的。在這筆贈款之後，費爾德曼在該公司的直接持股量增加到總共250,874股普通股。該交易的性質表明直接收購了股份，這反映了費爾德曼在公司的既得權益的潛在增加。
有用
沒用